Want to see HLSQ full AI Analyst Report?
Tessera Defense and Homeland Security (HLSQ) Stock Forecast & Price Target
HLSQ Analyst Ratings
There are no analyst ratings in the last 3 months.
HLSQ Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | H.C. Wainwright | ― | hold | ― | Downgraded | 03/09/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Joseph Pantginis | 03/09/26 | ― | hold | ― | Downgraded | H.C. Wainwright |
Best Analysts Covering Tessera Defense and Homeland Security
Copying PerPlexity Biotechnology's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +11.60% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +11.60% per trade.
Copying PerPlexity Biotechnology's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +11.60% per trade.
HLSQ Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, HLSQ has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HLSQ average Analyst price target in the past 3 months is ―.
HLSQ Financial Forecast
HLSQ Earnings Forecast
Next quarter’s earnings estimate for HLSQ is -$3.66 with a range of ― to ―. The previous quarter’s EPS was -$3.66. Its overall industry beat the EPS estimate 49.22% of the time in the past 12 months.
HLSQ Sales Forecast
Next quarter’s sales forecast for HLSQ is $332.00K with a range of ― to ―. The previous quarter’s sales results were $332.00K. Its overall industry beat sales estimates 53.85% of the time in the past 12 months.